ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

FATE Fate Therapeutics Inc

4.10
0.01 (0.24%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fate Therapeutics Inc FATE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.01 0.24% 4.10 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.12 3.925 4.22 4.10 4.09
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202415:30GLOBEFate Therapeutics Announces Presentation of FT819..
03/4/202407:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
02/4/202415:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
19/3/202407:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
05/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
04/3/202412:29EDGAR2Form 144 - Report of proposed sale of securities
01/3/202407:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
26/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202415:03EDGAR2Form 8-K - Current report
26/2/202415:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202407:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
12/2/202417:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
30/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202412:44EDGAR2Form 144 - Report of proposed sale of securities
25/1/202415:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:39EDGAR2Form 144 - Report of proposed sale of securities
09/1/202415:36EDGAR2Form 144 - Report of proposed sale of securities
09/1/202415:36EDGAR2Form 144 - Report of proposed sale of securities
09/1/202415:35EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
03/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202411:17EDGAR2Form 144 - Report of proposed sale of securities
19/12/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202310:40EDGAR2Form 144 - Report of proposed sale of securities
13/12/202316:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
27/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202310:57EDGAR2Form 144 - Report of proposed sale of securities
08/11/202316:10EDGAR2Form 8-K - Current report
08/11/202315:44EDGAR2Form S-3 - Registration statement under Securities Act of..
08/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:03EDGAR2Form 8-K - Current report
08/11/202315:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
25/10/202307:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
01/9/202316:29EDGAR2Form 8-K - Current report
31/8/202307:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
21/8/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202314:58EDGAR2Form 144 - Report of proposed sale of securities
08/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:07EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock